Faster Aggregation Method Development with Cutting Edge LC Technology
Available on demand
Protein therapeutics have a complexity far exceeding that of small molecule drugs, therefore, unraveling this complexity represents an analytical challenge. Size exclusion chromatography (SEC) is the method of choice for the quantification of aggregates in biotherapeutic samples.
In this webinar, Tim Rice, Global Outbound Product Manager, Bio-Columns, and Patrick Cronan, LC Applications Scientist, Agilent Technologies, will discuss tips and tricks for:
- Method optimization
- Choosing the right SEC column
- Selecting the correct buffer solution
Learn how to quickly choose and optimize the mobile phase composition for the aggregation analysis of monoclonal antibodies while increasing your throughput and reducing costs with AdvanceBio SEC columns.
Agilent Technologies